CJC-1295 – With DAC (5mg) Peptide

Description

A single-component research material supplied for controlled research environments. Suitable for studies involving GHRH-receptor pathway characterization and assay development in model systems.

Composition

• CJC-1295 (With DAC): 5 mg

• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

CJC-1295 – With DAC (5mg)

• Peptide identity and purity assessment via HPLC/LC-MS

• Assay development and calibration for quantitative analysis of GHRH-analog activity in vitro or ex vivo models

• Chromatographic method optimization for impurity profiling and peak resolution

• Stability characterization of a lyophilized peptide under laboratory storage conditions

Documentation

• COA pending — third-party verification in progress

Important Notice

• For research use only

• Not for human consumption

• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• COA pending — third-party verification in progress

• Lyophilized for transit stability; batch traceable

• Tamper-evident seal; lot & test date on each vial